104 related articles for article (PubMed ID: 15663560)
21. Nasal ECP patterns and specific immunotherapy in mite-allergic rhinitis patients.
Ferreira MB; Santos AS; Santos MC; Carlos ML; Barbosa MA; Carlos AG
Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):96-102. PubMed ID: 15918296
[TBL] [Abstract][Full Text] [Related]
22. Long-term allergen-specific immunotherapy correlates with long-term allergen-specific immunological tolerance.
Ali I; Goksal K; Ozan B; Gulsen D
Adv Ther; 2008 Jan; 25(1):29-36. PubMed ID: 18224290
[TBL] [Abstract][Full Text] [Related]
23. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
Kopp MV; Hamelmann E; Zielen S; Kamin W; Bergmann KC; Sieder C; Stenglein S; Seyfried S; Wahn U;
Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798
[TBL] [Abstract][Full Text] [Related]
24. [Allergen specific-IgG4 in circulating immune complexes in patients with inhalant allergy undergoing specific immunotherapy].
Rogala B; Jarzab J; Rymarczyk B; Tłuczykont B
Wiad Lek; 2004; 57(3-4):123-30. PubMed ID: 15307518
[TBL] [Abstract][Full Text] [Related]
25. Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC.
Savolainen J; Jacobsen L; Valovirta E
Allergy; 2006 Oct; 61(10):1184-90. PubMed ID: 16942566
[TBL] [Abstract][Full Text] [Related]
26. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.
Roberts G; Hurley C; Turcanu V; Lack G
J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125
[TBL] [Abstract][Full Text] [Related]
27. [Cluster-immunotherapy in seasonal allergic rhinitis: safety aspects of induction therapy with depot allergoids (Purethal)].
Hansen I; Hörmann K; Stuck BA; Schneider-Gêne S; Mösges R; Klimek L
Laryngorhinootologie; 2003 Aug; 82(8):558-63. PubMed ID: 12915987
[TBL] [Abstract][Full Text] [Related]
28. [Urticaria in relation to mite sensitivity and immunotherapy with Injection dermatophagoidei farinae].
Xing DR; Wen TH; Yu YL; Wei ZP; Li YM; Han T
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Dec; 26(6):422-7. PubMed ID: 19288915
[TBL] [Abstract][Full Text] [Related]
29. Impaired maturation of monocyte-derived dendritic cells from birch allergic individuals in association with birch-specific immune responses.
Casas R; Skarsvik S; Lindström A; Zetterström O; Duchén K
Scand J Immunol; 2007 Nov; 66(5):591-8. PubMed ID: 17868259
[TBL] [Abstract][Full Text] [Related]
30. Elevation of plasma soluble T cell costimulatory molecules CTLA-4, CD28 and CD80 in children with allergic asthma.
Ip WK; Wong CK; Leung TF; Lam CW
Int Arch Allergy Immunol; 2005 May; 137(1):45-52. PubMed ID: 15785081
[TBL] [Abstract][Full Text] [Related]
31. Immunological characteristics of subjects with asymptomatic skin sensitization to birch and grass pollen.
Assing K; Nielsen CH; Poulsen LK
Clin Exp Allergy; 2006 Mar; 36(3):283-92. PubMed ID: 16499638
[TBL] [Abstract][Full Text] [Related]
32. An observational study on outgrowing food allergy during non-birch pollen-specific, subcutaneous immunotherapy.
Alonso R; Enrique E; Pineda F; Basagaña M; San Miguel-Moncín MM; Bartra J; Palacios R; Cisteró-Bahíma A
Int Arch Allergy Immunol; 2007; 143(3):185-9. PubMed ID: 17284927
[TBL] [Abstract][Full Text] [Related]
33. [Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study].
Silny W; Czarnecka-Operacz M
Pol Merkur Lekarski; 2006 Dec; 21(126):558-65. PubMed ID: 17405298
[TBL] [Abstract][Full Text] [Related]
34. Activation of tumor-infiltrating antigen presenting cells by high intensity focused ultrasound ablation of human breast cancer.
Xu ZL; Zhu XQ; Lu P; Zhou Q; Zhang J; Wu F
Ultrasound Med Biol; 2009 Jan; 35(1):50-7. PubMed ID: 18950932
[TBL] [Abstract][Full Text] [Related]
35. [The effect of specific immunotherapy on serum eotaxin level in patients with pollinosis: preliminary studies].
Jahnz-Rózyk K; Głodzińska-Wyszogrodzka E; Rozyńska-Polańska R; Paluchowska E; Zabielski LS
Pol Merkur Lekarski; 2001 Sep; 11(63):244-6. PubMed ID: 11761820
[TBL] [Abstract][Full Text] [Related]
36. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of iron deficiency on the expression of CD80 and CD86 co-stimulatory receptors in mitogen-treated and untreated murine spleen cells.
Kuvibidila SR; Porretta C
J Cell Biochem; 2002; 86(3):571-82. PubMed ID: 12210763
[TBL] [Abstract][Full Text] [Related]
38. IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: effect of immunotherapy.
Nouri-Aria KT; Pilette C; Jacobson MR; Watanabe H; Durham SR
J Allergy Clin Immunol; 2005 Jul; 116(1):73-9. PubMed ID: 15990777
[TBL] [Abstract][Full Text] [Related]
39. The effects of allergen-specific immunotherapy on polymorphonuclear leukocyte functions in patients with seasonal allergic rhinitis.
Soyoğul Gürer U; Büyüköztürk S; Palandüz S; Rayaman E; Colakoglu B; Cevikbaş A
Int Immunopharmacol; 2005 Apr; 5(4):661-6. PubMed ID: 15710335
[TBL] [Abstract][Full Text] [Related]
40. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
Panzner P; Petrás M; Sýkora T; Lesná I
Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]